Applovin
APP · NASDAQ
About APP
- Employees
- 898
- Headquarters
- Palo Alto, California
- Listed
- Apr 15, 2021
- Sector
- Information Technology
- Industry
- Software
- Website
- applovin.com
APP key statistics
- Market cap
- 90.06B
- Price-earnings ratio
- 20.69
- Dividend yield
- —
- Average volume
- 4.88M
- Volume
- 1.80M
- Open price
- $269.33
- High today
- $277.44
- Low today
- $267.28
- 52 Week high
- $738.01
- 52 Week low
- $260.59
Applovin (APP) at a glance
Applovin (APP) last traded at $272.46, with a market cap of 90.06B and a price-to-earnings ratio of 20.69.
Today the stock has traded between $267.28 and $277.44. The current price is 1.9% above the day's low and 1.8% below its high.
Volume so far is 1.80M shares, below the average of 4.88M shares a day.
Over the past year Applovin has ranged from $260.59 to $738.01, and now sits 2% of the way up that range.
Applovin met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $3.76 per share against an estimate of $3.76.
The average analyst price target is $510.98, 87.5% above the current price, from 21 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy76.2%
- Hold23.8%
- Sell0.0%
- Low
- $328.25
- Now
- $272.46
- High
- $829.50
APP earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 19.3% on average.
- Q3 FY24: reported $1.25 per share against an estimate of $0.9333
- Q4 FY24: reported $1.73 per share against an estimate of $1.25
- Q1 FY25: reported $2.22 per share against an estimate of $1.47
- Q2 FY25: reported $2.39 per share against an estimate of $2.05
- Q3 FY25: reported $2.45 per share against an estimate of $2.42
- Q4 FY25: reported $3.24 per share against an estimate of $2.96
- Q1 FY26: reported $3.56 per share against an estimate of $3.44
- Q2 FY26: reported $3.76 per share against an estimate of $3.76
APP news
- Press releaseGlobe Newswire
- Press releasePRNewswire
APP INVESTOR DEADLINE: AppLovin Corporation Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action
- Press releasePRNewswire
Investor Alert: AppLovin (APP) has been Sued for Securities Fraud Over Alleged Misstatements made to Investors
- Press releaseNewsfile
Kaplan Fox Alerts AppLovin Corporation (APP) Investors of Substantial Losses to a Securities Class Action - Critical Deadline is November 16, 2026
- Press releaseGlobe Newswire
AppLovin (APP) Faces Securities Fraud Class Action Amid Concerns Over Model Improvements – Hagens Berman
- Press releasePRNewswire
AppLovin Corporation (APP) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact KTMC
- Press releaseGlobe Newswire
Kaplan Fox Reminds Investors of AppLovin Corporation (NASDAQ: APP) to a Securities Class Action Deadline – Contact the Firm Before November 16, 2026
- Press releaseGlobe Newswire
APP Stockholders Have Rights – If You Lost Money Investing in AppLovin Corporation Contact Robbins LLP for Information About Recovering Your Losses
Similar companies
Companies in the same industry as Applovin
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.